What CLN types have specific treatments?

CLN2 (TPP1 deficiency): cerliponase alfa (Brineura) ICV infusion 300 mg every 2 weeks dramatically slows neurological decline; CLN3 (Batten classic): cysteamine + N-acetylcysteine in trials; CLN1: miglustat in trials; all others: symptomatic only.

What is the Hamburg NCL scoring system?

CLN2 HAMBURGS motor, language, and seizure domains 0-3 each (total 0-9); score 6: initiates cerliponase; every 2-week ICV infusions under general anesthesia; score 0: disease too advanced for treatment; score stabilization or deceleration confirms treatment response.

What genetic testing strategy is used for NCL diagnosis?

Gene panel including CLN1-14; PPT1 and TPP1 enzyme assay in DBS or leukocytes confirms CLN1/2; electron microscopy of skin or conjunctival biopsy shows characteristic storage patterns (granular, curvilinear, fingerprint profiles) for each NCL subtype.

What features distinguish CLN2 from CLN3 Batten disease?

CLN2 (late infantile): myoclonic seizures and language regression at 2-4 years, rapid decline; CLN3 (juvenile Batten): visual failure first at 5-7 years, then behavioral/cognitive decline and seizures; CLN3 most common form globally.

What complications require monitoring during cerliponase alfa treatment?

ICV catheter-related infections, device malfunction, hypersensitivity reactions during infusion; monitor CSF cell count periodically; anti-drug antibodies in CSF; general anesthesia risks with every 2-week administrations; respiratory monitoring for progressive disease.

Neuronal Ceroid Lipofuscinosis (Batten Disease) Clinical Staging

Stages neuronal ceroid lipofuscinosis (CLN1-14) using HAMBURGS unified Batten disease rating scale, PPT1/TPP1 enzyme activity confirmation, and cerliponase alfa (CLN2) dosing and infusion monitoring.

Use the full interactive calculator below, or

Related Calculators

X-ALD Brain Score

Medical Calculators

Krabbe GLD Stage

Medical Calculators

Metabolic Syndrome Risk

Medical Calculators

Neuronal Ceroid Lipofuscinosis (Batten Disease) Clinical Staging

Related Calculators

Frequently Asked Questions

What CLN types have specific treatments?

What is the Hamburg NCL scoring system?

What genetic testing strategy is used for NCL diagnosis?

What features distinguish CLN2 from CLN3 Batten disease?

What complications require monitoring during cerliponase alfa treatment?